Corbus Pharmaceuticals Holdings, Inc. operates as a clinical-stage pharmaceutical company. The Company focuses on the development and commercialization of candidate and lenabasum novel therapeutic drugs to treat inflammatory and fibrotic diseases. Corbus Pharmaceuticals Holdings offers its services in Europe, Israel, and Australia.